Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10891508 | chr11:112983809 | G/A | 0.00019 | 174 | 25.87 | 19.72 | 36.73 | KM Plot |
PCPG | rs10906667 | chr10:14448568 | C/T | 1.63E-6 | 178 | 10.3 | 25.42 | 25.87 | KM Plot |
PCPG | rs1091424 | chr17:3257629 | A/C | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs1091590 | chr17:3255028 | A/G | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs10927051 | chr1:243805936 | G/C | 0.000319 | 170 | 25 | 25.53 | 18.35 | KM Plot |
PCPG | rs10927076 | chr1:243958293 | A/G | 0.000144 | 174 | 24.52 | 28.3 | 19.87 | KM Plot |
PCPG | rs10929269 | chr2:239097423 | A/G | 3.21E-5 | 171 | 29.43 | 16.97 | 13.22 | KM Plot |
PCPG | rs10935209 | chr3:136639099 | A/T | 0.000296 | 176 | 20.2 | 27.27 | 23.03 | KM Plot |
PCPG | rs10950054 | chr7:66315664 | C/T | 0.000223 | 177 | 24.85 | 29.57 | 33.17 | KM Plot |
PCPG | rs10958336 | chr8:53841318 | G/A | 5.03E-5 | 172 | 24.47 | 27.27 | 20 | KM Plot |
PCPG | rs10972736 | chr9:36122297 | C/T | 4.62E-5 | 178 | 20.48 | 24.23 | 25.53 | KM Plot |
PCPG | rs10993911 | chr9:136935697 | C/G | 5.12E-7 | 176 | 25.6 | 21.55 | 31.47 | KM Plot |
PCPG | rs10993924 | chr9:136943067 | C/T | 1.82E-5 | 178 | 28.57 | 23.53 | 25.4 | KM Plot |
PCPG | rs11017095 | chr10:131932337 | G/C | 1.11E-16 | 173 | 25.47 | 27.22 | 3.17 | KM Plot |
PCPG | rs11017096 | chr10:131932670 | T/C | 1.11E-16 | 173 | 25.47 | 27.22 | 3.17 | KM Plot |